Title: Active Lung Fibrosis up to 17 Years after Chemotherapy with Carmustine (BCNU) in Childhood
Abstract: Carmustine (BCNU) is an anticancer drug known to produce pulmonary fibrosis as a side effect within three years of treatment. It is not known whether pulmonary fibrosis can appear later.